Table 2.
Diagnostic performance of CE US LI-RADS and ultrasomics
| Entire cohort | Validation cohort | P | |||
|---|---|---|---|---|---|
| LI-RADS | Ultrasomics | LI-RADS | Ultrasomics | ||
| Sensitivity | 67.0 (57.2−75.8) | 97.2 (92.0−99.4) | 81.3 (63.6−92.8) | 90.6 (75.0−98.0) | 0.476 |
| Specificity | 73.6 (59.7−84.7) | 96.2 (87.0−99.5) | 87.5 (61.7−98.4) | 87.5 (61.7−98.4) | 1.000 |
| PPV | 83.5 (76.0−89.0) | 98.1 (93.3−99.8) | 92.9 (77.9−98.0) | 93.5 (78.6−99.2) | 1.000 |
| NPV | 52.7 (44.8−60.4) | 94.4 (84.6−98.8) | 70.0 (52.6−83.1) | 82.4 (56.6−96.2) | 0.257 |
| Accuracy | 69.2% (61.4−76.3) | 96.2% (93.3−99.2) | 83.3% (69.8−92.5) | 90.0% (80.9−98.2) | 0.552 |
| AUC* | 0.703 (0.625−0.773) | 0.981 (0.946−0.996) | 0.844 (0.710−0.932) | 0.895 (0.772−0.965) | 0.501 |
Data are percentages, with 95% confidence interval in parentheses
aData are area under the ROC curve, with 95% confidence interval in parentheses